diagnosis

News

Novartis taps Atropos AI for earlier PNH diagnoses

Novartis teams up with real-world evidence specialist Atropos Health, hoping to speed up the diagnosis and treatment of rare disease PNH.

R&D

The diagnostic odyssey: Challenges and opportunities in tran...

Transthyretin amyloidosis (ATTR) is a rarely diagnosed and relentless disease that demands our attention.

News

FDA clears first blood test for Alzheimer's disease

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis.

News

Prof Vanessa Raymont of the University of Oxford

UK sets aside £2m for digitally-enhanced dementia tests

The UK is providing £2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia.

News

Rishi Sunak becomes prostate cancer ambassador

Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for its campaign for a national screening programme.

News

Boost to Enhertu's prospects as FDA clears Roche diagnostic

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

Novartis taps Atropos AI for earlier PNH diagnoses

The diagnostic odyssey: Challenges and opportunities in tran...

FDA clears first blood test for Alzheimer's disease

UK sets aside £2m for digitally-enhanced dementia tests

Rishi Sunak becomes prostate cancer ambassador

Boost to Enhertu's prospects as FDA clears Roche diagnostic

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

diagnosis

Editor's Picks